Gurugram-based SyncMedia acquires Adorithm for $1 million
by Maria Thomas
Updated Jun 15, 2020
As part of the acquisition, SyncMedia, which enables marketers to accurately measure media performance and optimise it across linear and digital video, would absorb the Adorithm team, its product as well as its intellectual property/intellectual rights.
Co-founded in 2019 by Prakhar Gupta, Amit Duggal and Shashank Pathak, Adorithm uses modern day Artificial Intelligence (AI)/Machine Learning (ML) algorithms to help brand marketers, agencies and start-ups drive better performance of their media spends.
Adorithm is also based in Gurugram.
SyncMedia counts HUL, Vivo, Apple, H&M, Philips, Pizza Hut, Maruti, Ford, Pepsi, Lufthansa, Ultratech, Samsung, Mankind, and 3M among its growing list of clients.
"With this acquisition, we will be able to cater to our customers with deep insights backed by enhanced AI/ ML expertise," Anubhav Sharma, Founder and CEO, SyncMedia, said in a statement.
"Our solution provides sophisticated cause-and-effect analytics revealing the optimisation opportunities for brands, media agencies and broadcasters. We are aiming around 100 per cent growth in revenues with our increased focus on digital-first companies."
Incepted in 2017 by Sharma, SyncMedia has been delivering analytics to its customers through data-driven technology, thereby helping them in better media planning and delivery in a cost efficient manner.
Related Articles
- Optical Illusion Brain Test: If you have Sharp Eyes Find the Number 442 in 20 Secs
- London-based firm Nothing to release its Phone (2)
- Covid will continue to cause mini-waves, not become seasonal yet: Scientists
- Hackers offering crypto accounts for as low as $30 on darknet
- Reddit's new feature to allow users to share its content on other platforms
- Surgical masks can help kids fight respiratory infections: Study
- LinkedIn's new AI feature to write messages to hiring team
- Microsoft introduces Xbox Game Pass' new Friend Referral programme
- Disbursed over Rs 31 cr in claims to delivery partners in FY22-23: Swiggy
- India emerging as favourable destination for clinical trials: Report